Masimo Corp. (MASI)

139.02 +1.11 (+0.80%) USD  |  NASDAQ  |  Jan 09, 16:00
139.60 +0.58 (+0.42%) After-Hours: 20:00
More

Masimo Research and Development Expense (Annual): 222.80M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for MASI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
West Pharmaceutical Services, Inc. 69.10M
Boston Scientific Corp. 1.615B
Merit Medical Systems, Inc. 87.47M
Insulet Corp. 219.60M
UFP Technologies, Inc. 10.40M